Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase EARLY_PHASE1 2Phase 2/3 2Phase 1 2Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Breast Neoplasms 7Stomach Neoplasms 3Lung Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Multiple Myeloma 2Carcinoma, Transitional Cell 2Carcinoma, Renal Cell 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

pembrolizumab 4Magnetic Resonance Spectroscopy 4Radiotherapy 3Nivolumab 3Cetuximab 3fluoromisonidazole 2durvalumab 2Neoadjuvant Therapy 2Metformin 2Immunohistochemistry 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Cisplatin 2sitravatinib 1ruxolitinib 1ribociclib 1fluciclovine F-18 1dornase alfa 1avelumab 1antitumor A 1alovudine 1Varenicline 1Valproic Acid 1VTX-2337 1TAK-981 1Surgical Procedures, Operative 1Raltegravir Potassium 1Radiotherapy, Intensity-Modulated 1Plastic Surgery Procedures 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Squamous Cell Carcinoma of Head and Neck × Fluorodeoxyglucose F18 × Clear all
NCT06914999 2025-10-22

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

Emory University

Phase EARLY_PHASE1 Recruiting
20 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms

NCT00757549 2017-10-31

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Mayo Clinic

Phase EARLY_PHASE1 Completed
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡